Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era

Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation

(2012) Man-Hsin Hung et al.   ANNALS OF HEMATOLOGY

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma

(2011) Yu-Chung Huang et al.   ANNALS OF HEMATOLOGY

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

(2010) B. Coiffier et al.   BLOOD

Selecting an optimal staging system for hepatocellular carcinoma

(2010) Chia-Yang Hsu et al.   CANCER

Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494

(2010) J. N. Winter et al.   CLINICAL CANCER RESEARCH

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

(2010) Marita Ziepert et al.   JOURNAL OF CLINICAL ONCOLOGY

Relevance of the International Prognostic Index in the Rituximab Era

(2010) Kevin Tay et al.   JOURNAL OF CLINICAL ONCOLOGY

Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma

(2010) L F Porrata et al.   LEUKEMIA

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story

(2009) A. Bari et al.   ANNALS OF ONCOLOGY

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

(2009) Isabelle Ray-Coquard et al.   CANCER RESEARCH

Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma

(2008) M. Christina Cox et al.   BRITISH JOURNAL OF HAEMATOLOGY

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

(2008) Bruce D. Cheson et al.   NEW ENGLAND JOURNAL OF MEDICINE